The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor

Abstract

These results demonstrate that GPNMB may exert its neuroprotective effect through reducing astrocyte-mediated neuroinflammation in a CD44-dependent manner, providing novel mechanistic insight into the neuroprotective properties of GPNMB.